Orchard to build $80m gene therapy manufacturing facility
Orchard signed a long-term lease agreement to build-out an $80m gene therapy manufacturing facility in Fremont, California.
Archives for December 14, 2018
BIO EUROPE 2018
European biotech an attractive option for Chinese investment, says VC exec
Chinese investors are looking abroad for technology that will provide short-term returns and long-term health benefits to its large patient population, according to Panacea Ventures partner.